Centre for Gynae Oncology At Fortis Cancer Institute
About the Centre for Gynae Oncology At Fortis Cancer Institute
At the Fortis Centre for Gynae Oncology, we are dedicated to caring for women with cancers of the reproductive organs such as the uterus, cervix, ovaries, vulva, and vagina with empathy, precision and commitment. What sets us apart is our belief that cancer care should treat more than just the disease, it should care for the woman, every step of the way.
We recognize that every woman’s cancer journey is deeply personal. Whether it’s a new diagnosis or ongoing treatment, your concerns, life goals and emotions matter. That’s why we tailor our approach to fit not just your medical needs, but also your life circumstances, preferences, and personal values.
Our Centre brings together a team of highly skilled gynecologic oncologists, surgeons trained in minimally invasive and robotic procedures, radiation oncologists, medical oncologists, pathologists, genetic counselors, and fertility specialists. This team works closely and consistently to create a personalized, integrated care plan that addresses every aspect of your health.
We use the most advanced diagnostic tools and therapies available ranging from high-definition imaging and molecular testing to targeted therapies, immunotherapy, and precision guided radiation. For complex cases or recurrent cancers, we offer access to innovative treatment options through national and global clinical trials. Our focus is not only on curing the disease but also on preserving quality of life whether that means fertility preservation, sexual health support, or long-term survivorship care.
We understand that cancer care doesn’t stop at surgery, radiation or chemotherapy. It includes everything that helps you feel whole again. That’s why we offer a comprehensive support system psychological counseling, pain and symptom relief, nutritional advice, physiotherapy, support groups, and dedicated survivorship programs so you feel cared for in body, mind, and spirit.
For young women planning a family, those navigating menopause, or older women dealing with age-related challenges, we offer specialized care tailored to life stages. Whether your need is urgent or long-term, we are here with the expertise and empathy to guide you.
At Fortis, we are not just delivering care we are building relationships. Every patient is seen, heard, and supported as a whole person, not a diagnosis. With science on our side and compassion at our core, we are redefining what it means to care for women with cancer.
"Because here at Fortis, care isn’t just about treating cancer. It’s about treating you—with dignity, empathy, and unwavering excellence."
Key USPs
Women-Centric Cancer Expertise
Experienced oncologists focused exclusively on women’s healthMinimally Invasive Surgical Mastery
Advanced laparoscopic and robotic surgeriesIntegrated Team
Seamless coordination among oncology, surgery, radiology, pathology, and allied servicesGenomic-Driven Treatment Planning
Personalized therapies guided by molecular profilingSupport Beyond Medical Treatment
Emotional, nutritional, and survivorship support for the patients
-
Comprehensive Cancer Care for Women, With You at the Center
We bring together the best of medical science with a woman-centered approach. Our care teams are composed of Internationally trained gynecologic oncologists, surgical experts, radiation oncologists, genetic counselors, pathologists, fertility preservation specialists, and patient navigators. What makes our model stand out is its integrated, multidisciplinary design ensuring that you won’t have to navigate your treatment alone or juggle appointments across multiple specialists. Here, your care is coordinated under one roof, with a focus on your comfort, dignity, and preferences.
We also believe in evidence-based, personalized medicine. Every treatment plan is tailored to the patient’s individual disease type, genetic profile, age, fertility goals, and overall health. Our tumor boards—comprised of experts from multiple disciplines—meet regularly to discuss complex cases and recommend the best treatment strategies in line with international guidelines.Because we know that treating cancer means caring for more than just the disease.
-
Advancing the Future of Women’s Cancer Care
At Fortis, Innovation drives our Gynae Oncology Center. We are not only focused on today’s treatments but also actively engaged in shaping tomorrow’s cures. Our research-led approach ensures that patients have access to the most current advancements in gynecologic cancer care delivered safely, locally, and under expert supervision.
As a part of an academic medical network, our centers contribute to and benefits from ongoing clinical trials and translational research initiatives. Patients may qualify for studies evaluating novel immunotherapies, targeted agents, or surgical techniques sometimes available only at select institutions nationwide. Participation in these trials offers eligible women access to potentially life-extending therapies before they are widely accessible.
-
Key Technological Capabilities
• Advanced Robotic Surgery
Our center performs high-precision minimally invasive surgeries using robotic systems. These techniques reduce pain, scarring, blood loss, and recovery time—while maintaining surgical accuracy.
• Intraoperative Navigation and Imaging
With real-time visualization tools, surgeons can operate with enhanced clarity and control, particularly in complex pelvic procedures.
• Targeted Chemotherapy and Hormonal Therapy
Treatments are tailored not just to cancer type, but to the specific genetic behavior of the tumor, improving effectiveness while reducing toxicity.
• Fertility-Preserving Techniques
For younger women, we offer surgical and medical approaches that aim to preserve fertility where medically safe and feasible—integrating care with reproductive medicine experts.
Our Hospitals
-
Fortis Memorial Research Institute, Gurgaon
4.5
Medical Procedures
View all
FAQs
-
What Does a Gynecologic Oncologist Do?
A gynecologic oncologist is a specialist doctor who focuses on diagnosing and treating cancers that affect the female reproductive system. This includes cancers of the ovaries, uterus, cervix, vagina, vulva, and other related organs. -
What Happens If My Pap Smear Is Abnormal?
An abnormal Pap smear result doesn’t mean you have cancer, but it does indicate that further evaluation is needed. Your doctor may recommend a follow-up procedure called a colposcopy, which is typically done in the clinic and is generally well-tolerated.
During a colposcopy, a magnifying device called a colposcope is used to closely examine the cervix, and sometimes the vagina and vulva. A mild vinegar-like solution (acetic acid) is applied to the area, which may cause a brief stinging or burning sensation. This solution helps highlight any abnormal cells.
If any suspicious areas are seen, a small biopsy may be taken for further analysis. This might cause mild cramping, but the discomfort is usually short-lived.
Early follow-up and diagnosis are key to preventing the progression of cervical abnormalities. Your healthcare team will guide you through the next steps with care and support.
-
What Is the Difference Between Stage and Grade in Cancer?
When discussing cancer, stage and grade are two important terms that help guide diagnosis and treatment, but they refer to different aspects of the disease.
•Stage refers to how far the cancer has spread in the body. In gynecologic cancers, stages range from I to IV.
o Stage I and II typically indicate that the cancer is still localized or limited to nearby areas—this is considered early-stage disease.
o Stage III and IV suggest that the cancer has spread to other tissues or organs and is classified as advanced-stage disease.
•Grade describes how the cancer cells look under a microscope compared to normal, healthy cells. It gives insight into how aggressive the cancer might be.
o Gynecologic cancers are usually classified into Grade 1, 2, or 3, with Grade 1 being well-differentiated (less aggressive) and Grade 3 being poorly differentiated (more aggressive).
Understanding both the stage and grade of a cancer helps our care team create the most effective treatment plan tailored to your condition.
-
What Is a CA-125 Test?
The CA-125 test is a blood test that measures the level of a protein called cancer antigen 125, which is sometimes released into the bloodstream by certain types of cancer—most notably ovarian cancer.
While it can be helpful in monitoring treatment response or disease progression in women already diagnosed with ovarian cancer, it is not recommended as a general screening tool. This is because CA-125 levels can also be elevated in non-cancerous conditions such as menstruation, endometriosis, pelvic inflammatory disease, and even during pregnancy.
In clinical practice, the CA-125 test is most commonly used to track ovarian cancer over time, helping your care team assess how well treatment is working or if the cancer has returned.
-
How Often Should I Get a Pap Smear?
The timing of Pap smear screenings can vary based on your age and medical history. Here are the general guidelines:
•Ages 21 to 29:
Women in this age group should have a Pap smear every 3 years, provided their results are normal.
•Ages 30 to 65:
You have a few safe options for screening:
o Pap test alone every 3 years, or
o HPV test alone every 5 years, or
o A combined Pap and HPV test (co-testing) every 5 years
•Age 65 and above:
If you’ve had consistently normal results and no history of high-risk conditions, you may no longer need regular screening. Your doctor will help decide what’s best for you.
If you’ve had abnormal results, a weakened immune system, or a history of cervical issues, your doctor may recommend more frequent testing.
-
What Are the Common Cancer Antigen Tests in Gynecologic Cancers?
Cancer antigen (CA) tests measure specific proteins that may be elevated in the blood when certain types of gynecologic cancers are present. These tests are often used to monitor disease progression, evaluate treatment response, or check for recurrence—not typically for screening.
Here are the key antigen tests used in gynecologic cancers:
•CA-125
Most commonly used in ovarian cancer. Elevated levels can indicate the presence or recurrence of disease but may also rise in benign conditions like endometriosis or menstruation.
•HE4 (Human Epididymis Protein 4)
Often used alongside CA-125 to improve diagnostic accuracy in ovarian cancer, especially in differentiating between benign and malignant pelvic masses.
•CA 19-9
Sometimes elevated in mucinous ovarian tumors or gastrointestinal cancers. Not specific to gynecologic cancer but occasionally used as a supportive marker.
•CEA (Carcinoembryonic Antigen)
May be elevated in advanced cervical or ovarian cancers. It’s a non-specific marker but can help in tracking certain cases.
•SCC (Squamous Cell Carcinoma Antigen)
Most relevant in cervical cancer, particularly squamous cell types. Helps in monitoring treatment response and recurrence.
•Beta-hCG (Human Chorionic Gonadotropin)
Used in diagnosing and monitoring gestational trophoblastic disease or certain rare ovarian tumors.
These markers are part of a broader diagnostic approach. Your doctor will interpret these tests along with imaging, biopsies, and clinical findings to create the most accurate picture of your condition.
-
What is FNAC?
Fine-Needle Aspiration Cytology (FNAC) is a simple, quick, and minimally invasive diagnostic test used to investigate lumps or swellings in the body. During the procedure, a very thin needle is inserted into the area of concern such as the thyroid, breast, lymph node, or other soft tissue to extract a small sample of cells or fluid. Later these samples are examined under a microscope to check for infections, inflammation, or cancer.
FNAC is often the first step in evaluating whether a lump is benign (non-cancerous) or malignant (cancerous). It is commonly used because it is cost-effective, relatively painless, does not require anesthesia in most cases, and rarely causes complications.
The procedure usually takes about 10–15 minutes and is done on an outpatient basis. If the lump is deep or not easily felt, ultrasound or CT scan guidance may be used to improve accuracy. Most people experience only mild discomfort similar to a blood test and can return to their normal routine shortly after.
In most cases, the results are available within 2 to 4 days. If the sample doesn’t provide enough information, your doctor may recommend repeating the test or doing a more detailed biopsy.
FNAC is a safe and reliable tool that helps doctors make quicker decisions about further treatment or observation often avoiding the need for more invasive surgery unless absolutely necessary. -
What is a True Cut Biopsy and why is it done?
A True Cut biopsy is a type of core needle biopsy used to collect a small, solid piece of tissue from a lump or organ for diagnostic evaluation. It is performed using a special spring-loaded needle (often called a Tru-Cut needle) that removes a cylindrical core of tissue, allowing pathologists to examine the cellular structure in detail. Unlike fine needle aspiration (FNA), which collects cells or fluid, a True Cut biopsy provides more information about the architecture of the tissue, making it especially useful for diagnosing cancers, infections, or fibrotic conditions. This procedure is usually done under local anesthesia, often with imaging guidance like ultrasound or CT scan, and is considered minimally invasive. It’s commonly used for the breast, liver, kidney, lymph nodes, and soft tissue masses, among others. The results from a True Cut biopsy help doctors confirm a diagnosis, classify a tumor, or plan appropriate treatment all with minimal discomfort and quick recovery for the patient.